You are here
The Independent Hospital Pricing Authority (IHPA) is established under the National Health Reform Act 2011 (Cwlth) (the Act), and by virtue of section 131(1) of the Act is invested with the following functions relevant to this National Efficient Cost Determination 2020–21 (Determination):
The purpose of the Policy is to outline the processes by which IHPA adjusts for instability in the year-on-year price weights and adjustments.
The purpose of the Assessing Materiality of Changes Proposed to the National Pricing Model document is to outline the process IHPA follows when assessing the materiality of proposed changes to the national pricing models such as the introduction of new adjustments or alternative pricing policy approaches.
There is a growing discussion in Australia and internationally about the need to increase focus on delivering value-based health care with a focus on patient outcomes and experience.
IHPA’s Pricing Guidelines and the National Health Reform Agreement include provisions for IHPA to consider the impact on its work of evidence‑based, effective new technologies and innovations in models of health care.
The Public Interest Disclosure Act 2013 (the Act) regulates the internal reporting of suspected wrongdoing or disclosable conduct within public sector agencies. It provides a framework and protections for public officials who make eligible disclosures under the Act.
The IHPA Data Access and Release Policy (formerly Information Release Policy) outlines the principles and processes adopted by IHPA in the discretionary access and release of data under the National Health Reform Agreement and the National Health Reform Act 2011.
The ICD-10-AM/ACHI/ACS classification system is comprised of the following classifications:
- International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM)
- Australian Classification of Health Interventions (ACHI)
- Australian Coding Standards (ACS)
ICD-10-AM/ACHI/ACS Eleventh Edition is published as a set of five volumes which contain the following products:
The National Health Reform Act 2011 (the Act), section 131(1)(f), provides that IHPA will determine the public hospital functions that are to be funded in the states and territories by the Commonwealth, except where otherwise agreed between the Commonwealth and a state or territory.
The Independent Hospital Pricing Authority (Pricing Authority) is established under the National Health Reform Act 2011 (Cth) (the Act), and by virtue of section 131(1) of the Act is invested with the following functions relevant to this 2019-20 National Efficient Cost Determination (Determination):
This document provides an overview of the content of the ATTC Version 1.0 including the scope, structure and relevant activities.
Hospital Teaching, Training and Research Activities National Best Endeavours Data Set 2018-19 Technical Specifications for reporting5 July 2018
This document outlines the reporting requirements for the provision of data against the HTTRA NBEDS 2018-19 by state and territory health departments, including:
This document provides background to the development of the new classification, explains the data elements and collection protocols, reporting requirements, and how the data is grouped.
The Back-casting Policy outlines the process IHPA follows when back-casting the NEP or the NEC for the purpose of the calculation of the Commonwealth’s funding, as set out in the NHRA (clause A40).
The Independent Hospital Pricing Authority (Pricing Authority) is established under the National Health Reform Act 2011 (Cth) (the Act), and by virtue of section 131(1) of the Act is invested with the following functions relevant to this 2018-19 National Efficient Cost Determination (Determination):
Bundled pricing is where a single price covers a full package of care over a defined period of time, spanning multiple events and settings of care. The intention is for resources and funding to be easier for hospitals to manage, to allow financial flexibility to encourage improved models of care or greater standardisation of evidence-based care, and drive better service delivery in the long run which should lead to better patient outcomes and lower costs.